Dr. sc. hum. Henrik Jungaberle is a public health, prevention, and drug researcher. His focus is on human development, integration, and integrity in the use of psychoactive substances – and shaping this on the individual, social and political level. He develops and implements strategies to avoid or minimize the negative consequences of alcohol and other drug use (e.g. REBOUND). On the other hand, he works on strategies to sustain and improve health through the professional application of psychedelic substances. Currently, he is part of the research team in the EPIsoDE study – a psilocybin-assisted depression treatment trial.

Henrik Jungaberle is the director and co-founder of the MIND Foundation and with Prof. Dr. med. Gerhard Gründer one of the CEO’s of OVID Health Systems. OVID is dedicated to clinical excellence (OVID Clinic Berlin) and drug development (OVID Molecules). At MIND he has initiated and supported the development of 14 programs – among these, Henrik is one of the Scientific Directors of the INSIGHT Conference(s).

For 18 years, he has worked at the Institute of Medical Psychology, University Hospital Heidelberg  (1996-2014), where he conducted and led EU- and DFG-financed research on salutogenesis and psychoactive substances.

ORCID | researchgate | google scholar | Website